美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
16571-737-06	16571-737	HUMAN PRESCRIPTION DRUG	PROPAFENONE HYDROCHLORIDE	PROPAFENONE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20201216	N/A	ANDA	ANDA205956	Rising Pharma Holdings, Inc.	PROPAFENONE HYDROCHLORIDE	325 mg/1	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16571-737-06)
16571-737-50	16571-737	HUMAN PRESCRIPTION DRUG	PROPAFENONE HYDROCHLORIDE	PROPAFENONE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20201216	N/A	ANDA	ANDA205956	Rising Pharma Holdings, Inc.	PROPAFENONE HYDROCHLORIDE	325 mg/1	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16571-737-50)
16571-736-06	16571-736	HUMAN PRESCRIPTION DRUG	PROPAFENONE HYDROCHLORIDE	PROPAFENONE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20201216	N/A	ANDA	ANDA205956	Rising Pharma Holdings, Inc.	PROPAFENONE HYDROCHLORIDE	225 mg/1	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16571-736-06)
16571-736-50	16571-736	HUMAN PRESCRIPTION DRUG	PROPAFENONE HYDROCHLORIDE	PROPAFENONE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20201216	N/A	ANDA	ANDA205956	Rising Pharma Holdings, Inc.	PROPAFENONE HYDROCHLORIDE	225 mg/1	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16571-736-50)
16571-738-06	16571-738	HUMAN PRESCRIPTION DRUG	PROPAFENONE HYDROCHLORIDE	PROPAFENONE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20201216	N/A	ANDA	ANDA205956	Rising Pharma Holdings, Inc.	PROPAFENONE HYDROCHLORIDE	425 mg/1	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16571-738-06)
16571-738-50	16571-738	HUMAN PRESCRIPTION DRUG	PROPAFENONE HYDROCHLORIDE	PROPAFENONE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20201216	N/A	ANDA	ANDA205956	Rising Pharma Holdings, Inc.	PROPAFENONE HYDROCHLORIDE	425 mg/1	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16571-738-50)